Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

Completed · Not applicable

Conditions studied: End Stage Renal Disease (ESRD)

In brief

To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port protector.

Key facts

Study ID

NCT02593149

Run by

Pursuit Vascular, Inc.

People needed

1902

Starts

2015-11-01

Expected to finish

2016-11-01

Last updated by the study team

2019-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients dialyzing with a central venous catheter

You may not qualify if…

• Known allergy to chlorhexidine

Where it is running

• DaVita Clinical Research — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.